Overview

A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
A new drug for overactive bladder is compared to placebo to determine if it is safe and effective. The study lasts approximately 12 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
Watson Pharmaceuticals
Treatments:
Mandelic Acids
Oxybutynin